Clinical TrialsSearch results
Number of results: 386
Other
- Registration Program for Myelodysplastic Syndromes and Aplastic Anemia
- Myelodysplastic Syndromes Aplastic Anemia
- Keio University School of Medicine
- 2007-04-28
Other
- Specimen Aquisition Program and Genetic Analysis for Myelodysplastic Syndromes
- Myelodysplastic Syndromes
- Keio University School of Medicine
- 2007-04-28
Other
- Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
- Multiple myeloma expressing CD20
- Zenyaku Kogyo Co., Ltd.
- 2006-11-28
Other
- Cytogenetic features and its clinical implications in Japanese patients with multiple myeloma: retrospective analysis by Japan Myeloma Study Group
- multiple myeloma
- Japan Myeloma Study Group
- 2008-09-22
Other
- Combination therapy of melphalan plus prednisolone and zoledronic acid for untreated multiple myeloma patients ineligible for autologous stem cell transplantation
- Multiple Myeloma
- Myeloma Bone Disease Study Group
- 2008-10-17
Not yet recruiting
- Clinical study of MP plus zoledronic acid therapy in newly diagnosed multiple myeloma excluding stem cell transplantation patients
- Multiple Myeloma
- Division of clinial oncology and hematology, Jikei University School of Medicine
- 2009-07-06
Recruiting
- A Study of Teclistamab in Combination with Daratumumab Subcutaneously (SC) (Tec-Dara) versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants with Relapsed or Refractory Multiple Myeloma
- Multiple Myeloma
- Nishikawa Kazuk
- 2022-03-02
Other
- Japan Cooperative SPECT Study of Mild Impairment of Cognitive Function
- Mild Cognitive Impairment
- J-COSMIC Executive Committee
- 2006-08-15
Other
- MCA Embolism Local Fibrinolytic Intervention Trial
- Middle cerebral artery embolism
- MELT Study Group
- 2005-09-08
Other
- Randomized study of Taxane vs TS-1 in metastatic or recurrent breast cancer patients
- Metastatic or recurrent breast cancer
- SELECT BC executive committee
- 2006-06-01